The Patent Finder

Terms ending in 2038

Ono Pharmaceutical Co., Ltd.

Every in-force patent on Ono Pharmaceutical Co., Ltd.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,836,747Ethane-Sulfonate Salt of Quinoline Derivative
In force
 · High confidence
Ono Pharmaceutical Co., Ltd.In forceHigh confidence
US 11,851,428Activator of Trek (TWIK Related K+ Channels) Channels
In force
 · High confidence
Ono Pharmaceutical Co., Ltd.In forceHigh confidence
US 11,479,550EP4 Antagonist
In force
 · High confidence
Ono Pharmaceutical Co., Ltd.In forceHigh confidence
US 11,826,363Therapeutic Agent for Solid Cancers, Which Comprises Axl Inhibitor as Active Ingredient
In force
 · High confidence
Ono Pharmaceutical Co., Ltd. and Kyoto Prefectural Public University CorporationIn forceHigh confidence
US 10,617,667Method for Treating Brain Tumors
In force
 · High confidence
The Regents of the University of CaliforniaIn forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Ono Pharmaceutical Co., Ltd..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited